Rajesh Sripada


Director, Business Intelligence

As Director / Program Manager of Business Intelligence, Rajesh Sripada manages the implementation and development of Business Intelligence (BI) Solutions. Sripada’s work experience includes providing strategic solutions for advancing BI at the Food and Drug Administration (FDA). His responsibilities at Aurotech are specific to the growth of Business Intelligence and encompass business development, client relations and overseeing the tools and training needed to meet Aurotech’s consistently growing needs in information technology.

Sripada was instrumental in introducing the latest BI tools at the FDA – including visualization, data exploration and self-service reporting tools. He also incorporated a powerful in-memory backend for faster reporting performance. Sripada leads the FDA project and oversees full life-cycle development. As the lead, he is responsible for the project teams – from planning through execution – while specifically establishing applications requirements, user interface security/design and application risks.

Sripada is consistently recognized for technical delivery, performance and a superior focus on customer loyalty, technological refresh strategy, and data quality management.

Prior to Aurotech, Sripada spent 9 years at Information Innovators Inc (formerly known as GlobalNet Services Inc) supporting the FDA as both the lead and manager of Business Intelligence projects. Sripada has a proven record of identifying, strategizing and managing implementation solutions. His strengths include big data solutions, i.e. SAP HANA, healthcare solutions, web traffic analytics, software technologies, and end-to-end product introduction and enablement. His product skills include various BI tools from SAP, Tableau and Qlik Sense.

Sripada’s education includes a MS degree in Applied Information Technology from Towson University in MD, a diploma in International Business from Philadelphia University in PA, and an MBA in Marketing and Finance from the University of Wollongong, Australia.